Stock Events

BioGaia AB (publ) 

SEK126
6
+SEK1.3+1.04% Friday 15:29

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
13.16B
P/E Ratio
35.41
Dividend Yield
1.51%
Dividend
1.9

Upcoming

8
MAY 25
Dividend Ex
15
MAY 25
Dividend Payment
8
MAY 26
Dividend Ex
15
MAY 26
Dividend Payment

Dividends

1.51%Dividend Yield
May 24
SEK5
May 24
SEK1.9
May 23
SEK1.45
May 23
SEK1.45
May 22
SEK0.29
10Y Growth
22.57%
5Y Growth
42.44%
3Y Growth
90.97%
1Y Growth
31.03%

Earnings

7MayConfirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0
0.33
0.65
0.98
Expected EPS
0.9798688147199999
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIOG-B.ST. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Daiichi Sankyo.
DSKYF
Mkt Cap68.54B
Danisco (DuPont Nutrition & Biosciences) offers probiotic strains that compete directly with BioGaia's products in the dietary supplement market.
Chervon Limited
CHRHF
Mkt Cap1.25B
Chr. Hansen Holding A/S specializes in probiotic and natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries, directly competing with BioGaia's probiotic offerings.
Novonesis AS
NVZMY
Mkt Cap25.23B
Novozymes provides bioinnovation, including probiotics that can be used in various applications, competing in the same space as BioGaia.
Kerry
KRYAF
Mkt Cap14.96B
Kerry Group offers nutritional and functional ingredients, including probiotics, that compete with BioGaia's range of products.
BeiGene
BGNE
Mkt Cap15B
BeiGene is involved in biopharmaceuticals, and while its focus is more on oncology, its expansion into health and wellness products could position it as a competitor to BioGaia.
Herbalife
HLF
Mkt Cap1.12B
Herbalife Nutrition offers dietary supplements, including probiotics, competing in the same market as BioGaia.
Amarin
AMRN
Mkt Cap77.54M
Amarin Corporation focuses on cardiovascular health products, but its interest in overall health could lead to expansion into areas like probiotics, making it a potential competitor to BioGaia.

About

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment provides packaging solutions. It sells its products through distribution partners or through its own distribution channels. BioGaia AB (publ) was founded in 1990 and is based in Stockholm, Sweden.
Show more...
CEO
Mr. Peter Rothschild M.Sc. Econ., MBA
Employees
211
Country
SE
ISIN
SE0017769995
WKN
000A3DL7T

Listings

OTCM
US
BIOGY
F
DE
BGLA.F
ST
Sweden
BIOG-B.ST
OTCM
US
BGLAF